-
Je něco špatně v tomto záznamu ?
Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration
S. Foldynová-Trantírková, P. Sekyrová, K. Tmejová, E. Brumovská, O. Bernatík, W. Blankenfeldt, P. Krejcí, A. Kozubík, T. Dolezal, L. Trantírek, V. Bryja,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
NLK
BioMedCentral
od 1999-12-01
BioMedCentral Open Access
od 1999
Directory of Open Access Journals
od 2000
Free Medical Journals
od 1999 do Před 2 roky
PubMed Central
od 1999
Europe PubMed Central
od 1999
Open Access Digital Library
od 1999-07-01
Open Access Digital Library
od 1999-01-01
Open Access Digital Library
od 2000-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1999
Springer Nature OA/Free Journals
od 1999-12-01
PubMed
20507565
DOI
10.1186/bcr2581
Knihovny.cz E-zdroje
- MeSH
- beta-katenin metabolismus MeSH
- buněčná adheze MeSH
- duktální karcinom prsu genetika metabolismus patologie MeSH
- fosforylace MeSH
- imunoprecipitace MeSH
- kaseinkinasa Iepsilon chemie genetika metabolismus MeSH
- konformace proteinů MeSH
- lidé MeSH
- MAP kinasa-kinasa 4 metabolismus MeSH
- messenger RNA genetika MeSH
- mutace genetika MeSH
- nádorové buněčné linie MeSH
- nádory prsu genetika metabolismus patologie MeSH
- pohyb buněk MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- proliferace buněk MeSH
- proteiny Wnt metabolismus MeSH
- rac1 protein vázající GTP metabolismus MeSH
- transkripční faktory NFATC metabolismus MeSH
- western blotting MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
INTRODUCTION: Breast cancer is one of the most common types of cancer in women. One of the genes that were found mutated in breast cancer is casein kinase 1 epsilon (CK1epsilon). Because CK1epsilon is a crucial regulator of the Wnt signaling cascades, we determined how these CK1epsilon mutations interfere with the Wnt pathway and affect the behavior of epithelial breast cancer cell lines. METHODS: We performed in silico modeling of various mutations and analyzed the kinase activity of the CK1epsilon mutants both in vitro and in vivo. Furthermore, we used reporter and small GTPase assays to identify how mutation of CK1epsilon affects different branches of the Wnt signaling pathway. Based on these results, we employed cell adhesion and cell migration assays in MCF7 cells to demonstrate a crucial role for CK1epsilon in these processes. RESULTS: In silico modeling and in vivo data showed that autophosphorylation at Thr 44, a site adjacent to the breast cancer point mutations in the N-terminal lobe of human CK1epsilon, is involved in positive regulation of the CK1epsilon activity. Our data further demonstrate that, in mammalian cells, mutated forms of CK1epsilon failed to affect the intracellular localization and phosphorylation of Dvl2; we were able to demonstrate that CK1epsilon mutants were unable to enhance Dvl-induced TCF/LEF-mediated transcription, that CK1epsilon mutants acted as loss-of-function in the Wnt/beta-catenin pathway, and that CK1epsilon mutants activated the noncanonical Wnt/Rac-1 and NFAT pathways, similar to pharmacological inhibitors of CK1. In line with these findings, inhibition of CK1 promoted cell migration as well as decreased cell adhesion and E-cadherin expression in the breast cancer-derived cell line MCF7. CONCLUSIONS: In summary, these data suggest that the mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration. In terms of molecular mechanism, our data indicate that the breast cancer point mutations in the N-terminal lobe of CK1epsilon, which are correlated with decreased phosphorylation activities of mutated forms of CK1epsilon both in vitro and in vivo, interfere with positive autophosphorylation at Thr 44.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026374
- 003
- CZ-PrNML
- 005
- 20121206122801.0
- 007
- ta
- 008
- 120817e20100527enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1186/bcr2581 $2 doi
- 035 __
- $a (PubMed)20507565
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Foldynová-Trantírková, Silvie $u Biology Centre AS CR, v,v,i, AND University of South Bohemia, Branisovska 31, Ceske Budejovice, Czech Republic. fosil@paru.cas.cz
- 245 10
- $a Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration / $c S. Foldynová-Trantírková, P. Sekyrová, K. Tmejová, E. Brumovská, O. Bernatík, W. Blankenfeldt, P. Krejcí, A. Kozubík, T. Dolezal, L. Trantírek, V. Bryja,
- 520 9_
- $a INTRODUCTION: Breast cancer is one of the most common types of cancer in women. One of the genes that were found mutated in breast cancer is casein kinase 1 epsilon (CK1epsilon). Because CK1epsilon is a crucial regulator of the Wnt signaling cascades, we determined how these CK1epsilon mutations interfere with the Wnt pathway and affect the behavior of epithelial breast cancer cell lines. METHODS: We performed in silico modeling of various mutations and analyzed the kinase activity of the CK1epsilon mutants both in vitro and in vivo. Furthermore, we used reporter and small GTPase assays to identify how mutation of CK1epsilon affects different branches of the Wnt signaling pathway. Based on these results, we employed cell adhesion and cell migration assays in MCF7 cells to demonstrate a crucial role for CK1epsilon in these processes. RESULTS: In silico modeling and in vivo data showed that autophosphorylation at Thr 44, a site adjacent to the breast cancer point mutations in the N-terminal lobe of human CK1epsilon, is involved in positive regulation of the CK1epsilon activity. Our data further demonstrate that, in mammalian cells, mutated forms of CK1epsilon failed to affect the intracellular localization and phosphorylation of Dvl2; we were able to demonstrate that CK1epsilon mutants were unable to enhance Dvl-induced TCF/LEF-mediated transcription, that CK1epsilon mutants acted as loss-of-function in the Wnt/beta-catenin pathway, and that CK1epsilon mutants activated the noncanonical Wnt/Rac-1 and NFAT pathways, similar to pharmacological inhibitors of CK1. In line with these findings, inhibition of CK1 promoted cell migration as well as decreased cell adhesion and E-cadherin expression in the breast cancer-derived cell line MCF7. CONCLUSIONS: In summary, these data suggest that the mutations of CK1epsilon found in breast cancer can suppress Wnt/beta-catenin as well as promote the Wnt/Rac-1/JNK and Wnt/NFAT pathways, thus contributing to breast cancer development via effects on cell adhesion and migration. In terms of molecular mechanism, our data indicate that the breast cancer point mutations in the N-terminal lobe of CK1epsilon, which are correlated with decreased phosphorylation activities of mutated forms of CK1epsilon both in vitro and in vivo, interfere with positive autophosphorylation at Thr 44.
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a nádory prsu $x genetika $x metabolismus $x patologie $7 D001943
- 650 _2
- $a duktální karcinom prsu $x genetika $x metabolismus $x patologie $7 D018270
- 650 _2
- $a kaseinkinasa Iepsilon $x chemie $x genetika $x metabolismus $7 D048149
- 650 _2
- $a buněčná adheze $7 D002448
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a pohyb buněk $7 D002465
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoprecipitace $7 D047468
- 650 _2
- $a MAP kinasa-kinasa 4 $x metabolismus $7 D048670
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a transkripční faktory NFATC $x metabolismus $7 D050778
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a proteiny Wnt $x metabolismus $7 D051153
- 650 _2
- $a beta-katenin $x metabolismus $7 D051176
- 650 _2
- $a rac1 protein vázající GTP $x metabolismus $7 D020830
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sekyrová, Petra
- 700 1_
- $a Tmejová, Katerina
- 700 1_
- $a Brumovská, Eva
- 700 1_
- $a Bernatík, Ondrej
- 700 1_
- $a Blankenfeldt, Wulf
- 700 1_
- $a Krejcí, Pavel
- 700 1_
- $a Kozubík, Alois
- 700 1_
- $a Dolezal, Tomás
- 700 1_
- $a Trantírek, Lukás
- 700 1_
- $a Bryja, Vítezslav
- 773 0_
- $w MED00006602 $t Breast cancer research : BCR $x 1465-542X $g Roč. 12, č. 3 (20100527), s. R30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20507565 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121206122834 $b ABA008
- 999 __
- $a ok $b bmc $g 948416 $s 783720
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 12 $c 3 $d R30 $e 20100527 $i 1465-542X $m Breast cancer research $n Breast Cancer Res $x MED00006602
- LZP __
- $a Pubmed-20120817/10/04